Investors' claims for compensation from delisted Procomp Informatics Co (博達科技) may exceed NT$5 billion, with over 10,000 claims in total, the Securities and Futures Investors Protection Center estimated yesterday.
One day after prosecutors indicted Procomp's top management and suggested up to a 20-year sentence for chairwoman Sophie Yeh (葉素菲), the center said it expected to receive more complaints from another batch of stock investors who bought the chipmaker's shares in 2000. Prosecutors have now concluded that the company faked financial reports one year earlier than previously thought.
"Since the law allows a five-year retroactive period to seek compensation from defaulted companies, investors, who bought Procomp's shares in 2000, better hurry to file lawsuits [against it] before Nov. 15," said Michael Chao (
The center will receive investors' complaints for the next 10 days ahead of the Nov. 15 deadline, Chao said.
The center had previously received over 8,000 compensation applications for convertible bonds worth NT$1.6 billion and securities worth NT$2.36 billion from the chipmaker, which was ejected from the main bourse in late June after defaulting on a NT$2.98 billion bond payment.
The center estimates that the total compensation from the first batch of 8,000 investors may be between NT$3 billion to NT$4 billion while the second batch may increase the total amount to over NT$5 billion.
Separately, the Financial Supervisory Commission also urged Bank SinoPac (建華銀行) to reshuffle top management in its overseas re-investment subsidiaries after the commission found the subsidiaries had failed to use due diligence in dealing with Procomp.
Top management at SinoPac's parent holding company double as the top management of overseas subsidiaries, but the jurisdiction of the parent company's top management may not cover overseas subsidiaries, said Jong Huey-jen (鍾慧貞), director-general of the commission's Bureau of Monetary Affairs.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained